Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024

24 Oct 2024

Abstract excerpt

CDC continues to track the evolution of SARS-CoV-2, including the Omicron variant and its descendants, using national genomic surveillance. This report summarizes U.S. trends in variant proportion estimates during May 2023-September 2024, a period when SARS-CoV-2 lineages primarily comprised descendants of Omicron variants XBB and JN.1. During summer and fall 2023, multiple descendants of XBB with immune escape...

Source

Identifiers

PMID: 39446667
DOI: 10.15585/mmwr.mm7342a1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024PMID 39446667Read ↗

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages — United States, January 2022–May 2023Semantic proximity Read ↗

Characteristics of SARS-CoV-2 Omicron BA.5 variants in Shanghai after ending the zero-COVID policy in December 2022: a clinical and genomic analysisSemantic proximity Read ↗

Tracking SARS-CoV-2 Variants During the 2023 Flu Season and Beyond in LebanonSemantic proximity Read ↗

Emerging Omicron Subvariants EG.5 and BA.2.86: Implications for COVID-19 Immunity and SurveillanceSemantic proximity Read ↗

SARS-CoV-2 evolution in the Omicron era.Semantic proximity Read ↗

Genome surveillance of SARS-CoV-2 Omicron XBB subvariants in Wuhan in June 2023.Semantic proximity Read ↗

Emerging Omicron Subvariants EG.5 and BA.2.86: Implications for COVID-19 Immunity and SurveillanceSemantic proximity Read ↗

Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variantSemantic proximity Read ↗

Tracking SARS-CoV-2 Variants During the 2023 Flu Season and Beyond in LebanonSemantic proximity Read ↗

Genomic Surveillance Reveals the Rapid Expansion of the XBB Lineage among Circulating SARS-CoV-2 Omicron Lineages in Southeastern Wisconsin, USASemantic proximity Read ↗

Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected With Omicron Subvariants and the XBB Recombinant VariantSemantic proximity Read ↗

Integrated Genomic and Virological SARS-CoV-2 Surveillance in Germany 2022/23: Monitoring Viral Evolution and Epidemiological CharacteristicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.